📌 To learn more about Dr. Ajay Bhatnagar, visit prostatecancerusa.com

Three out of four men told their prostate cancer is "low risk" end up needing treatment anyway. That number isn't a scare tactic, it's published data that most patients on active surveillance never hear.

If your plan hasn't changed in months, you may not be in surveillance anymore. You may just be waiting. And the difference between those two things can change your outcome entirely.

In this episode, I'm going to walk you through the 5 signs that tell the difference between a prostate cancer plan that's actually working and one that's running on autopilot.

⏱️ TIMESTAMPS
0:00 - The statistic your doctor probably never told you
0:32 - Sign 1: Your PSA went up and nothing changed
1:13 - Why PSA velocity matters more than a single number
1:40 - Sign 2: You've never seen a side-by-side treatment comparison
2:03 - What published outcome data actually shows
2:42 - Sign 3: Brachytherapy was never mentioned
3:06 - What a 45-minute outpatient procedure can do
4:01 - Sign 4: "Low risk" was treated as a finish line
5:06 - Sign 5: Your surveillance has no defined trigger to act
5:31 - What to bring to your next appointment

❓ QUESTIONS ANSWERED

What does "low-risk" prostate cancer actually mean?
"Low risk" describes how your cancer looks today based on grade and stage. It says nothing about where it is headed. Roughly 75% of men on active surveillance eventually need active treatment, which means a watch-and-wait plan is not the same as a safe plan.

What is brachytherapy and why don't most doctors mention it?
Brachytherapy is a 45-minute outpatient prostate cancer procedure with a published cure rate above 98% for low and intermediate cases. Most doctors do not bring it up because they do not perform it themselves - meaning your options list may be incomplete before you ever make a decision.

How do you know if your active surveillance plan is too passive?
Key warning signs include a PSA that has risen two or more appointments in a row with no new biopsy ordered, no defined threshold for when treatment would start, and never being shown a comparison of all available treatment options. If none of those conversations have happened, your plan may be passive by default, not by design.

📱 RESOURCES
Website: https://www.remagin.com
Instagram: https://www.instagram.com/dr_rad_ajay/
TikTok: https://www.tiktok.com/@drradajay
YouTube: https://www.youtube.com/@DrAjayBhatnagar

🔔 Subscribe for straight breakdowns of prostate cancer treatment options, what the data actually shows, and what to ask before you make any decision.


ABOUT DR. AJAY BHATNAGAR:

Dr. Ajay Bhatnagar is a board-certified radiation oncologist and interventional oncologist with over 20 years of experience and more than 15,000 patients treated. He is the founder of the Prostate Cancer Institute of America and has dedicated the second half of his career to reviving LDR brachytherapy for men with localized prostate cancer across the country. He is the author of Modern Low Dose Rate Brachytherapy for Prostate Cancer: A Comprehensive Guide for Urologists.

#ProstateCancer #ProstateCancerTreatment #Brachytherapy #CancerTreatment #ProstateCancerSurvivor